Artificial Intelligence in Cardiovascular Care—Part 2: Applications
Sneha S. Jain(Palo Alto University), Thomas M. Maddox(BJC HealthCare), Marco Perez(Palo Alto University), Geoffrey H. Tison(Johns Hopkins Hospital), James P. Pirruccello(Broad Institute), Rohan Khera(Yale New Haven Hospital), Francisco López Jiménez(Mayo Clinic), Deepa Kumaraiah(NewYork–Presbyterian Hospital), Michael Randazzo(University of Chicago Medical Center), Andrew J. Einstein(NewYork–Presbyterian Hospital), Pierre Elias(Columbia University Irving Medical Center), Girish N. Nadkarni(Icahn School of Medicine at Mount Sinai), Michael Salerno(University of Virginia Health System), Emma Pierson(Cornell University), Timothy J. Poterucha(Mayo Clinic), David Ouyang(Kaiser Permanente), Jennifer N. Avari Silva(Saint Louis University), Robert Avram(Montreal Heart Institute), Vivek T. Natarajan(Google (United States)), Chris Haggerty(Presbyterian Healthcare Services), Ashley Beecy(Presbyterian Healthcare Services)
Cited by 62
Related Papers
Use of Machine Learning Models to Predict Death After Acute Myocardial Infarction
|JAMA Cardiology|2021|285
Analysis of cardiac magnetic resonance imaging in 36,000 individuals yields genetic insights into dilated cardiomyopathy
|Nature Communications|2020|264
Cardiac Tumors: Clinical Presentation, Diagnosis, and Management
|Current Treatment Options in Oncology|2019|213
More than an anticoagulant: Do heparins have direct anti-inflammatory effects?
|Thrombosis and Haemostasis|2016|201